2014 Q1 Form 10-Q Financial Statement

#000156066414000045 Filed on May 15, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $20.81K $45.45K
YoY Change -54.2% -79.29%
Cost Of Revenue $9.900K $26.89K
YoY Change -63.18% -87.03%
Gross Profit $10.91K $18.56K
YoY Change -41.19% 52.94%
Gross Profit Margin 52.44% 40.84%
Selling, General & Admin $290.0K $230.0K
YoY Change 26.09% -36.11%
% of Gross Profit 2657.14% 1239.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.068K $19.46K
YoY Change -79.1% -59.81%
% of Gross Profit 37.27% 104.87%
Operating Expenses $292.8K $233.2K
YoY Change 25.51% -34.41%
Operating Profit -$281.8K -$214.7K
YoY Change 31.28% -37.5%
Interest Expense -$9.239K $5.950K
YoY Change -255.28%
% of Operating Profit
Other Income/Expense, Net -$1.495M -$40.64K
YoY Change 3579.42%
Pretax Income -$1.780M -$260.0K
YoY Change 584.62% -23.53%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.777M -$255.3K
YoY Change 596.02% -25.67%
Net Earnings / Revenue -8537.91% -561.81%
Basic Earnings Per Share
Diluted Earnings Per Share -$922.3K -$218.5K
COMMON SHARES
Basic Shares Outstanding 144.9M shares 89.34M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.0K $10.00K
YoY Change 900.0% -90.0%
Cash & Equivalents $101.5K $6.033K
Short-Term Investments
Other Short-Term Assets $31.59K $130.7K
YoY Change -75.83% 9743.83%
Inventory $1.310K $1.557K
Prepaid Expenses
Receivables $0.00 $10.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $137.1K $152.7K
YoY Change -10.25% 18.83%
LONG-TERM ASSETS
Property, Plant & Equipment $5.099K $84.11K
YoY Change -93.94% -68.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $116.4K $110.1K
YoY Change 5.74% -62.21%
TOTAL ASSETS
Total Short-Term Assets $137.1K $152.7K
Total Long-Term Assets $116.4K $110.1K
Total Assets $253.5K $262.8K
YoY Change -3.55% -37.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $330.0K $420.0K
YoY Change -21.43% 147.06%
Deferred Revenue
YoY Change
Short-Term Debt $140.0K $30.00K
YoY Change 366.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.221M $792.9K
YoY Change 53.98% 96.58%
LONG-TERM LIABILITIES
Long-Term Debt $270.0K $0.00
YoY Change
Other Long-Term Liabilities $1.490M
YoY Change
Total Long-Term Liabilities $1.760M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.221M $792.9K
Total Long-Term Liabilities $1.760M $0.00
Total Liabilities $2.975M $792.9K
YoY Change 275.15% 96.58%
SHAREHOLDERS EQUITY
Retained Earnings -$17.21M -$14.19M
YoY Change 21.34% 8.65%
Common Stock $148.5K $92.46K
YoY Change 60.61% 22.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.721M -$530.1K
YoY Change
Total Liabilities & Shareholders Equity $253.5K $262.8K
YoY Change -3.55% -37.4%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$1.777M -$255.3K
YoY Change 596.02% -25.67%
Depreciation, Depletion And Amortization $4.068K $19.46K
YoY Change -79.1% -59.81%
Cash From Operating Activities -$134.3K -$54.62K
YoY Change 145.87% -58.15%
INVESTING ACTIVITIES
Capital Expenditures -$1.445K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.445K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $172.5K $30.00K
YoY Change 475.0% -80.26%
NET CHANGE
Cash From Operating Activities -$134.3K -$54.62K
Cash From Investing Activities -$1.445K $0.00
Cash From Financing Activities $172.5K $30.00K
Net Change In Cash $36.77K -$24.62K
YoY Change -249.37% -453.42%
FREE CASH FLOW
Cash From Operating Activities -$134.3K -$54.62K
Capital Expenditures -$1.445K $0.00
Free Cash Flow -$132.8K -$54.62K
YoY Change 143.23% -62.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
GTX Corp
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001375793
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014Q1 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
156099555 shares
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64754 usd
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30649 usd
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
101523 usd
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6033 usd
CY2013Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1892 usd
CY2014Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
2640 usd
CY2013Q4 us-gaap Inventory Net
InventoryNet
766 usd
CY2014Q1 us-gaap Inventory Net
InventoryNet
1310 usd
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
27740 usd
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
31593 usd
CY2013Q4 us-gaap Assets Current
AssetsCurrent
95152 usd
CY2014Q1 us-gaap Assets Current
AssetsCurrent
137066 usd
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7722 usd
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5099 usd
CY2013Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
82222 usd
CY2014Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
111302 usd
CY2013Q4 us-gaap Assets
Assets
185096 usd
CY2014Q1 us-gaap Assets
Assets
253467 usd
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
340226 usd
CY2014Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
436176 usd
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
18991 usd
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
22569 usd
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
4000 usd
CY2014Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1500 usd
CY2013Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
90797 usd
CY2014Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
141475 usd
CY2013Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
70535 usd
CY2014Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
286051 usd
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
830799 usd
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1220921 usd
CY2013Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
237672 usd
CY2014Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
265177 usd
CY2013Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
411708 usd
CY2014Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1488573 usd
CY2013Q4 us-gaap Liabilities
Liabilities
1480179 usd
CY2014Q1 us-gaap Liabilities
Liabilities
2974671 usd
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
131352 usd
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
148503 usd
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14009430 usd
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14343238 usd
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15435865 usd
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17212945 usd
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-1295083 usd
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
-2721204 usd
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
185096 usd
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
253467 usd
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2071000000 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2071000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131352518 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
148502593 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131352518 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
148502593 shares
CY2014Q1 us-gaap Revenues
Revenues
20814 usd
CY2013Q1 us-gaap Revenues
Revenues
45446 usd
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
9900 usd
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
26887 usd
CY2014Q1 us-gaap Gross Profit
GrossProfit
10914 usd
CY2013Q1 us-gaap Gross Profit
GrossProfit
18559 usd
CY2014Q1 gtxo Wages And Professional Fees
WagesAndProfessionalFees
215228 usd
CY2013Q1 gtxo Wages And Professional Fees
WagesAndProfessionalFees
188487 usd
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
77522 usd
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44753 usd
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
292750 usd
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
233240 usd
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-281836 usd
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-214681 usd
CY2014Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-169463 usd
CY2013Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-35687 usd
CY2014Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1316452 usd
CY2013Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
999 usd
CY2014Q1 us-gaap Interest Expense
InterestExpense
9329 usd
CY2013Q1 us-gaap Interest Expense
InterestExpense
5950 usd
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1495244 usd
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-40638 usd
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-1777080 usd
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-255319 usd
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144896193 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89337501 shares
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2014Q1 us-gaap Depreciation
Depreciation
4068 usd
CY2013Q1 us-gaap Depreciation
Depreciation
19463 usd
CY2014Q1 us-gaap Impaired Assets To Be Disposed Of By Method Other Than Sale Amount Of Impairment Loss
ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss
0 usd
CY2013Q1 us-gaap Impaired Assets To Be Disposed Of By Method Other Than Sale Amount Of Impairment Loss
ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss
5062 usd
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
53171 usd
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
49915 usd
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-748 usd
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8329 usd
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-544 usd
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-25497 usd
CY2013Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2613 usd
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
95951 usd
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
36209 usd
CY2014Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
26900 usd
CY2013Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
57880 usd
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3578 usd
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8428 usd
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-134286 usd
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54616 usd
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1445 usd
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1445 usd
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2014Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
175000 usd
CY2013Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
25000 usd
CY2014Q1 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
0 usd
CY2013Q1 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
10000 usd
CY2014Q1 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
2500 usd
CY2013Q1 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
5000 usd
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
172500 usd
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30000 usd
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
36769 usd
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-24616 usd
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2013Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2014Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2013Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2014Q1 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
750 usd
CY2014Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
315351 usd
CY2014Q1 gtxo Issuance Of Convertible Debt For Insoles
IssuanceOfConvertibleDebtForInsoles
25000 usd
CY2013Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
32000 usd
CY2013Q1 gtxo Issuance Common Stock Accrued Interest
IssuanceCommonStockAccruedInterest
3200 usd
CY2013Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
120000 usd
CY2013Q1 gtxo Issuance Of Common Stock For Short Term Debt
IssuanceOfCommonStockForShortTermDebt
49187 usd
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
7720000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2000000 shares
CY2014Q1 us-gaap Reclassifications
Reclassifications
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Reclassifications</u></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For comparability, certain prior period amounts have been reclassified, where appropriate, to conform to the financial statement presentation used in 2014. These reclassifications have no impact on net loss.</p>
CY2014Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Basis of Presentation</u></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited consolidated financial statements of GTX have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and applicable regulations of the U.S. Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been omitted pursuant to such rules and regulations. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of financial position and results of operations have been included. Our operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. The accompanying unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements for the year ended December 31, 2013, which are included in our Annual Report on Form 10-K.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements reflect the accounts of GTX Corp and its wholly owned subsidiaries. All significant inter-company balances and transactions have been eliminated.</p>
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Use of Estimates</u></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the accompanying unaudited consolidated financial statements requires the use of estimates that affect the reported amounts of assets, liabilities, revenues, expenses and contingencies.&#160; These estimates include, but are not limited to, estimates related to revenue recognition, allowance for doubtful accounts, inventory valuation, tangible and intangible long-term asset valuation, warranty and other obligations and commitments.&#160; Estimates are updated on an ongoing basis and are evaluated based on historical experience and current circumstances.&#160; Changes in facts and circumstances in the future may give rise to changes in these estimates which may cause actual results to differ from current estimates.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>
CY2013Q4 gtxo Warrants Maximum Exercise Price
WarrantsMaximumExercisePrice
0.08
CY2014Q1 gtxo Warrants Maximum Exercise Price
WarrantsMaximumExercisePrice
0.02
CY2013Q4 gtxo Warrants Minimum Exercise Price
WarrantsMinimumExercisePrice
0.02
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
505246 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.25
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.079
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
-5720000 shares
CY2014Q1 gtxo Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercise Price Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisePriceForfeituresAndExpirations
.08
CY2014Q1 gtxo Schedule Of Warrant Activity
ScheduleOfWarrantActivity
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of the Company&#146;s warrant activity and related information is provided below:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; font: 11pt Times New Roman, Times, Serif; padding-right: -6.95pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: top; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td colspan="2" style="vertical-align: bottom; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; letter-spacing: 0pt"><b>Exercise Price $</b></font></td> <td colspan="2" style="vertical-align: top; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td colspan="4" style="vertical-align: bottom; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="letter-spacing: 0pt"><b>Number of</b></font></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="letter-spacing: 0pt"><b>Warrants</b></font></p></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: -6.95pt; padding-left: 5.4pt; text-align: justify">Outstanding and exercisable at December 31, 2013</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="border-top: Black 1.5pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td colspan="2" style="border-top: Black 1.5pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0.02 - 0.08</td> <td colspan="2" style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">7,720,000 </td></tr> <tr style="vertical-align: top; background-color: White"> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: -6.95pt; padding-left: 5.4pt; text-align: justify">Warrants exercised </td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td colspan="2" style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td colspan="2" style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">-</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: -6.95pt; padding-left: 5.4pt; text-align: justify">Warrants granted</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td colspan="2" style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td colspan="2" style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: top; background-color: White"> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: -6.95pt; padding-left: 5.4pt; text-align: justify">Warrants expired</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td colspan="2" style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0.08</td> <td colspan="2" style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(5,720,000)</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: -6.95pt; padding-left: 5.4pt; text-align: justify">Outstanding and exercisable at March 31, 2014</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td colspan="2" style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0.02</td> <td colspan="2" style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td style="font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="border-bottom: Black 1.5pt double; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="border-bottom: Black 1.5pt double; font: 11pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">2,000,000 </td></tr> <tr style="background-color: White"> <td>&#160;</td> <td style="width: 24px">&#160;</td> <td>&#160;</td> <td style="width: 89px">&#160;</td> <td style="width: 1px">&#160;</td> <td style="width: 15px">&#160;</td> <td style="width: 1px">&#160;</td> <td style="width: 19px">&#160;</td> <td style="width: 18px">&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y4M13D
CY2014Q1 gtxo Working Capital
WorkingCapital
-1083855 usd
CY2013Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
306250 usd
CY2014Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
333150 usd
CY2013Q4 gtxo Convertible Notes Payable Current Principal Balance
ConvertibleNotesPayableCurrentPrincipalBalance
142500 usd
CY2014Q1 gtxo Convertible Notes Payable Current Principal Balance
ConvertibleNotesPayableCurrentPrincipalBalance
192500 usd
CY2013Q4 us-gaap Debt Current
DebtCurrent
94797 usd
CY2014Q1 us-gaap Debt Current
DebtCurrent
142975 usd
CY2013Q4 gtxo Convertible Debt Noncurrent Principal Balance
ConvertibleDebtNoncurrentPrincipalBalance
730438 usd
CY2014Q1 gtxo Convertible Debt Noncurrent Principal Balance
ConvertibleDebtNoncurrentPrincipalBalance
902550 usd
CY2013Q4 gtxo Debt Instrument Unamortized Discount Non Current
DebtInstrumentUnamortizedDiscountNonCurrent
-492766 usd
CY2014Q1 gtxo Debt Instrument Unamortized Discount Non Current
DebtInstrumentUnamortizedDiscountNonCurrent
-637373 usd
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
200000 usd
CY2014Q1 gtxo Amount Of Tranche
AmountOfTranche
425000 usd
CY2014Q1 gtxo Tranche Obligation
TrancheObligation
901000 usd
CY2014Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
722603 usd
CY2014Q1 gtxo Shares Issued For Services Rendered Value
SharesIssuedForServicesRenderedValue
32075 usd
CY2014Q1 gtxo Shares Issued For Services Rendered Shares
SharesIssuedForServicesRenderedShares
2275000 shares
CY2014Q1 gtxo Shares Issued With Repurchase Rights Value
SharesIssuedWithRepurchaseRightsValue
3532 usd
CY2014Q1 gtxo Shares Issued With Repurchase Rights Shares
SharesIssuedWithRepurchaseRightsShares
750000 shares
CY2014Q1 gtxo Stock Issued During Period Value Conversion Of Convertible Debt
StockIssuedDuringPeriodValueConversionOfConvertibleDebt
315351 usd
CY2014Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
14125075 shares
CY2014Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
350958 usd
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
17150075 shares
CY2014Q1 gtxo Warrants Outstanding At.02 Exercise Price
WarrantsOutstandingAt.02ExercisePrice
2000000 shares
CY2014Q1 gtxo Remaining Life Of Warrants.02 Exercise Price In Years
RemainingLifeOfWarrants.02ExercisePriceInYears
P1Y5M7D
CY2014Q1 gtxo Warrants Exerciseable02 Exercise Price
WarrantsExerciseable02ExercisePrice
2000000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-269887 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
775133 shares
CY2013Q4 gtxo Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
46901 usd
CY2014Q1 gtxo Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
17362 usd
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
775133 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
505246 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.14
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.079
CY2013 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P1Y1M
CY2013Q4 gtxo Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantDateFairValue
46901 usd
CY2014Q1 gtxo Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantDateFairValue
17362 usd
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2014Q1 gtxo Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageGrantDateFairValue
-29539 usd
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2182000 shares
us-gaap Temporary Equity Contract Terms
TemporaryEquityContractTerms
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the SPA entered into with Atlantic on July 12, 2013 (See Note 4), the Company issued a Warrant to Atlantic, whereby Atlantic is entitled to purchase from the Company a total number of shares of common stock, such that, when added to the total number of shares of common stock acquired by Atlantic upon conversion of the Atlantic Note, equals 12% of the common stock outstanding as of the date of such conversion, as such total outstanding amount may, be increased by issuances of common stock occurring on or prior to November 13, 2014 (or by issuances of common stock occurring after November 13, 2014 but pursuant to convertible instruments issued or commitments made by the Company prior to November 13, 2014), other than issuances of excluded securities as such term is defined in the Atlantic Note, at an exercise price per share equal to $0.001 per share, at any time and from time to time on or after the Closing Date and through and including November 13, 2020. As of the March 31, 2014, Atlantic has not converted any portion of the Atlantic Note.</p>
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
7000000 shares
CY2014Q2 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
2649176 shares
CY2014Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
90072 usd
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
-51703 usd
CY2014Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
-51025 usd
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
0 usd
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
702550 usd
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
0 usd

Files In Submission

Name View Source Status
0001560664-14-000045-index-headers.html Edgar Link pending
0001560664-14-000045-index.html Edgar Link pending
0001560664-14-000045.txt Edgar Link pending
0001560664-14-000045-xbrl.zip Edgar Link pending
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gtxo-20140331.xsd Edgar Link pending
gtxo033114_10q.htm Edgar Link pending
gtxo033114_ex311.htm Edgar Link pending
gtxo033114_ex312.htm Edgar Link pending
gtxo033114_ex321.htm Edgar Link pending
gtxo033114_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
gtxo-20140331_cal.xml Edgar Link unprocessable
gtxo-20140331.xml Edgar Link completed
gtxo-20140331_lab.xml Edgar Link unprocessable
gtxo-20140331_def.xml Edgar Link unprocessable
gtxo-20140331_pre.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable